Memorial Sloan Kettering Cancer Center
2019 ASH Update on the First-Line Therapy in Follicular Lymphoma: Rituximab and Lenalidomide Have Similar Activity to ChemoIO w/ a Distinct Toxicity Profile
Login to view comments.
Click here to Login